Looking within the lesion: Large scale transcriptional profiling of psoriatic plaques

Table 2 Transcriptional profiling studies targeting psoriasis in the GEO database

	Microarrays	Platform	Samples	Ref.
Comparison studies
GSE34248	14 + 14	HG-U133_Plus_2	Lesional + NonLes	[21]
GSE41662	24 + 24	HG-U133_Plus_2	Lesional + NonLes	[21]
GSE41663	15 + 15 (+ 51 treated)	HG-U133_Plus_2	Lesional + NonLes	[21]
GSE30999	85 + 85	HG-U133_Plus_2	Lesional + NonLes	[19]
GSE11903	15 + 15 (+ 59 treated)	HG-U133A_2	Lesional + NonLes	[18]
GSE6710	13 + 13	HG-U133A	Lesional + NonLes	[24]
GSE14905	21 + 33 + 30	HG-U133_Plus_2	Healthy + Les + NonLes	[16]
GSE13355	64 + 58 + 58	HG-U133_Plus_2	Healthy + Les + NonLes	[12]
GSE32407	20 + 20 (+ 20 IFNg treated)	HG-U133A_2	Healthy + NonLes	[17]
Related studies
GSE42305			Monocytes	[54]
GSE41905			Kcytes transfected wt Antimir31	[55]
GSE31652			All lesional, treated placebo	[56]
GSE26952			Nonlesional only Psor AD	[57]
GSE18948			PBMCs	[58]
GSE11307			PCR study	1
GSE6601			Psor vs AD	[59]
GSE41745	3 + 3		RNA Sequencing	[60]
GSE26866	11 + 11 (different regions)	HG-U133A_2	Single vs double amplification	[61]
GSE30768	2 +4 (+ 8 flare and relapse)	HG-U133A_2	Small number of samples	[62]
GSE2737	3 + 4 + 4	HG_U95Av2	Small array	[63]

¹Shin J and Detmar M, unpublished. PBMCs: Peripheral blood mononuclear cell; PCR: Partido comunista revolucionario.